Prevalence of baseline NS3 resistance-associated substitutions (RASs) on treatment with protease inhibitors in patients infected with HCV genotype 1-Reference-Cited by-同舟云学术

Prevalence of baseline NS3 resistance-associated substitutions (RASs) on treatment with protease inhibitors in patients infected with HCV genotype 1

Published:2019-11 Issue:6 Volume:43 Page:700-706
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Costa Vanessa Duarte,Delvaux Nathália,Brandão-Mello Carlos Eduardo,Nunes Estevão Portela,de Sousa Paulo Sérgio Fonseca,de Souza Rodrigues Lia Laura Lewis Ximenez,Lampe Elisabeth,do Amaral Mello Francisco Campello

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference41 articles.

1. WHO. Prevalence of chronically infected people with hepatitis C virus (HCV) worldwide, http://www.who.int/news-room/fact-sheets/detail/hepatitis-c; 2018 [Accessed 28th April 2018].

2. The natural history of hepatitis C virus (HCV) infection;Chen;Int J Med Sci,2006

3. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource;Smith;Hepatology,2014

4. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region;Nakano;Liver Int,2012

5. Side effects of therapy for chronic hepatitis C;Russo;Gastroenterology,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review on the Evolution of Natural Mutation-dependent Antiviral Drug Resistance in Hepatitis C Virus (HCV) Genotypes Prevalent in Saudi Arabia: A Genomic and Therapeutic Perspective;The Natural Products Journal;2024-04-03

2. Molecular Mechanisms of Resistance to Direct-Acting Antiviral (DAA) Drugs for the Treatment of Hepatitis C Virus Infections;Diagnostics;2023-09-30

3. Frequency distribution of HCV resistance-associated variants in infected patients treated with direct-acting antivirals;International Journal of Infectious Diseases;2022-02

4. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients;Current HIV Research;2021-09

5. Natural prevalence of NS3 gene resistance-associated substitutions (RASs) in patients with chronic hepatitis C from the state of Pará/Brazil;Virus Research;2021-01